Jade Biosciences Inc
(JBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 26,165 | 24,618 | 22,066 | 21,368 | 20,336 |
| Operating Income | -26,165 | -24,618 | -22,066 | -21,368 | -20,336 |
| Other Income | 1,390 | 1,432 | 1,709 | 1,805 | 1,311 |
| Pre-tax Income | -24,775 | -23,186 | -20,357 | -19,563 | -19,025 |
| Net Income Continuous | -24,775 | -23,186 | -20,413 | -19,563 | -19,025 |
| Net Income | $-24,775 | $-23,186 | $-20,413 | $-19,563 | $-19,025 |
| EPS Basic Total Ops | -30.18 | -29.12 | -25.61 | -24.91 | -26.67 |
| EPS Basic Continuous Ops | -30.23 | -29.27 | -25.88 | -24.83 | -26.52 |
| EPS Diluted Total Ops | -30.18 | -29.12 | -25.61 | -24.91 | -26.67 |
| EPS Diluted Continuous Ops | -30.23 | -29.27 | -25.88 | -24.83 | -26.52 |
| EPS Diluted Before Non-Recurring Items | -30.18 | -29.12 | -25.97 | N/A | N/A |
| EBITDA(a) | $-26,829 | $-25,349 | $-22,977 | $-22,151 | $-20,953 |